MICHELLE LEON: Open Payments
NPI 1689824310 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 8 payments from 7 companies in 2025. Trend: 2023 $375 · 2024 $304 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $57 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| EMD Serono, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Eisai Inc. | 1 | $18 |
Products named: DARZALEX, GIVLAARI, WELIREG, NINLARO, MONJUVI, Lenvima.
Industry payments across CA — which companies pay providers there.
